PharmiWeb1h
BIAL Announces First Patient Out in its Phase 2 Clinical Trial of BIA 28-6156 - a Novel Therapy for GBA1 Parkinson's Disease
BIAL, a hundred-year-old innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, announced that the first patient has completed the full dose regimen in the ACTIVATE ...
PharmiWeb1h
Model N Appoints New Chief Executive Officer, Bret Connor
Model N, the leader in revenue optimization and compliance for life sciences and high-tech companies, has appointed Bret Connor as Chief Executive Officer.
PharmiWeb8h
tiakis Biotech AG Receives Positive Scientific Advice from the U.S. FDA for Planned Phase II Trial of Tiprelestat
Stanford University are preparing for a Phase II in Pulmonary Arterial Hypertension (PAH)Kiel, Germany, January 8, 2025 – ...
PharmiWeb2h
Biotech Startups Get a Boost: ZAGENO and Hatch.Bio Labs Partner to Streamline Lab Operations
ZAGENO Forms a Strategic Partnership With Hatch.Bio Labs, a Premier Biotech Incubator Online, January 8, 2025 (Newswire.com) - ...
PharmiWeb8h
Coulter Partners places seasoned life sciences and CRO leader as CEO of Metrion Biosciences
Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, ...
PharmiWeb4h
Jaguar Health Presenting January 13 at Lytham 2025 Investor Healthcare Summit & January 14 at Biotech Showcase
SAN FRANCISCO, CA / ACCESSWIRE / January 8, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the company's founder, president and CEO, will participate in a virtual fireside ...
PharmiWeb4h
The 2025 Black Book of Physician Practice Management Technology Released: A Competitive Intelligence Report
Free to participants in the 2025 survey of PM software, this comprehensive report offers critical insights into trends, developments, and vendor capabilities shaping the future of practice management.
PharmiWeb4h
IGC Pharma Names IGC-AD1 Phase 2 Clinical Trial for Alzheimer's Agitation "CALMA" and Expands Recruitment Strategy
Innovative use of geofencing technology boosts enrollment at select sites POTOMAC, MD / ACCESSWIRE / January 8, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") announced ...
PharmiWeb18h
Tiziana Life Sciences Announces Review Article Published in Nature Highlighting Foralumab's Potential in the Treatment of Neurological Disease
NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its ...
PharmiWeb4h
uniQure Announces Pricing of its Public Offering
Qure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced the pricing of its underwritten public offering of 4 ...
PharmiWeb4h
PureTech to Present at 43rd Annual J.P. Morgan Healthcare Conference
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today ...
PharmiWeb3h
StimCell Energetics Inc. Signs Marketing Agreement with Think Ink Marketing
VANCOUVER, BC / ACCESSWIRE / January 8, 2025 / StimCell Energetics Inc. (OTC PINK:STME) ("StimCell", or the "Company") a biotech company targeting cellular energy to promote anti-aging, longevity and ...